Glassman Wealth Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-48
| Closed | -$11.3K | – | 578 |
|
|
2023
Q4 | $11.3K | Buy |
48
+27
| +129% | +$6.38K | ﹤0.01% | 846 |
|
|
2023
Q3 | $4.12K | Hold |
21
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q2 | $4.42K | Sell |
21
-3
| -13% | -$631 | ﹤0.01% | 1032 |
|
|
2023
Q1 | $4.84K | Sell |
24
-206
| -90% | -$41.6K | ﹤0.01% | 1008 |
|
|
2022
Q4 | $50.1K | Buy |
230
+213
| +1,253% | +$46.4K | 0.01% | 422 |
|
|
2022
Q3 | $3K | Sell |
17
-12
| -41% | -$2.12K | ﹤0.01% | 1117 |
|
|
2022
Q2 | $6K | Buy |
29
+9
| +45% | +$1.86K | ﹤0.01% | 939 |
|
|
2022
Q1 | $6K | Sell |
20
-1
| -5% | -$300 | ﹤0.01% | 953 |
|
|
2021
Q4 | $8K | Buy |
21
+5
| +31% | +$1.91K | ﹤0.01% | 860 |
|
|
2021
Q3 | $7K | Buy |
16
+4
| +33% | +$1.75K | ﹤0.01% | 855 |
|
|
2021
Q2 | $4K | Buy |
12
+3
| +33% | +$1K | ﹤0.01% | 971 |
|
|
2021
Q1 | $3K | Hold |
9
| – | – | ﹤0.01% | 986 |
|
|
2020
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 1050 |
|
|
2020
Q3 | $2K | Hold |
9
| – | – | ﹤0.01% | 977 |
|
|
2020
Q2 | $2K | Hold |
9
| – | – | ﹤0.01% | 836 |
|
|
2020
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 838 |
|
|
2019
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 885 |
|
|
2019
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 807 |
|
|
2019
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 821 |
|
|
2019
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 779 |
|
|
2018
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 617 |
|
|
2018
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 662 |
|
|
2018
Q2 | $1K | Buy |
9
+6
| +200% | +$667 | ﹤0.01% | 642 |
|
|
2018
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 769 |
|